Energy News / Shareholders Foundation, Inc.

NASDAQ: LPCN Investor Alert: Lawsuit Alleges Misleading Statements by Lipocine Inc.

Via: ReleaseWire

Updated 12:00 PM CST, Mon, December 09,2019

A lawsuit was filed on behalf of investors in Lipocine Inc. (NASDAQ: LPCN) shares over alleged securities laws violations.

San Diego, CA -- (SBWIRE) -- 12/09/2019 -- An investor, who purchased shares of Lipocine Inc. (NASDAQ: LPCN), filed a lawsuit over alleged violations of Federal Securities Laws by Lipocine Inc.

Investors who purchased shares of Lipocine Inc. (NASDAQ: LPCN) have certain options and for certain investors are short and strict deadlines running. Deadline: January 14, 2020. NASDAQ: LPCN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiff claims that between March 27, 2019, and November 8, 2019, the defendants made false and/or misleading statements and/or failed to disclose that the results from Lipocine's clinical studies of TLANDO were insufficient to demonstrate the drug's efficacy, that accordingly, Lipocine's third NDA for TLANDO was highly likely to be found deficient by the FDA, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Lipocine Inc. (NASDAQ: LPCN) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdaq-lpcn-investor-alert-lawsuit-alleges-misleading-statements-by-lipocine-inc-1267489.htm

Media Relations Contact
Michael Daniels
1-858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com